Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Persson F, Desai AS, Nicolaides M, Richard A, Xiang Z, Brunel P, Pfeffer MA; ALTITUDE Investigators..

N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3.

2.

Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes.

Mäkinen VP, Forsblom C, Thorn LM, Wadén J, Gordin D, Heikkilä O, Hietala K, Kyllönen L, Kytö J, Rosengård-Bärlund M, Saraheimo M, Tolonen N, Parkkonen M, Kaski K, Ala-Korpela M, Groop PH; FinnDiane Study Group..

Diabetes. 2008 Sep;57(9):2480-7. doi: 10.2337/db08-0332. Epub 2008 Jun 10.

3.

Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension.

Hannila-Handelberg T, Kontula K, Tikkanen I, Tikkanen T, Fyhrquist F, Helin K, Fodstad H, Piippo K, Miettinen HE, Virtamo J, Krusius T, Sarna S, Gautschi I, Schild L, Hiltunen TP.

BMC Med Genet. 2005 Jan 20;6:4.

4.

Specification levels and collaborative definition for the integration of health information systems.

Mykkänen J, Tikkanen T, Rannanheimo J, Eerola A, Korpela M.

Stud Health Technol Inform. 2003;95:304-9.

PMID:
14664004
5.

Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.

Tikkanen I, Tikkanen T, Cao Z, Allen TJ, Davis BJ, Lassila M, Casley D, Johnston CI, Burrell LM, Cooper ME.

J Hypertens. 2002 Apr;20(4):707-14.

PMID:
11910307
6.

[When is blood pressure lowering needed?].

Tikkanen I, Tikkanen T.

Duodecim. 1999;115(8):945-9. Review. Finnish. No abstract available.

PMID:
11859528
7.

Surface UV retrieval from satellite data.

Tikkanen T.

Int J Circumpolar Health. 2000 Jan;59(1):9-14.

PMID:
10850001
8.

Predicting the outcome of invasive treatment of renal artery disease.

Helin KH, Lepäntalo M, Edgren J, Liewendahl K, Tikkanen T, Tikkanen I.

J Intern Med. 2000 Jan;247(1):105-10.

9.

Renoprotective effects of captopril in hypertension induced by nitric oxide synthase inhibition in experimental nephritis.

Uhlenius N, Tikkanen T, Miettinen A, Holthöfer H, Törnroth T, Eriksson A, Fyhrquist F, Tikkanen I.

Nephron. 1999 Feb;81(2):221-9.

PMID:
9933759
10.

Screening for renovascular hypertension in a population with relatively low prevalence.

Helin KH, Tikkanen I, von Knorring JE, Lepäntalo MJ, Liewendahl BK, Laasonen LS, Fyhrquist FY, Tikkanen T.

J Hypertens. 1998 Oct;16(10):1523-9.

PMID:
9814625
11.

Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.

Tikkanen T, Tikkanen I, Rockell MD, Allen TJ, Johnston CI, Cooper ME, Burrell LM.

Hypertension. 1998 Oct;32(4):778-85.

12.

[Bilateral Achilles tendon rupture caused by oral fluoroquinolones].

Mäki T, Heinäsmäki T, Riutta J, Tikkanen T, Laasonen L, Eklund K.

Duodecim. 1996;112(19):1818-20. Finnish. No abstract available.

PMID:
10596182
13.

Chronic inhibition of nitric oxide synthase in Heymann nephritis.

Uhlenius N, Tikkanen I, Tikkanen T, Miettinen A, Törnroth T, Fyhrquist F.

Nephron. 1996;74(1):144-9.

PMID:
8883033
14.

Polymorphism of the glycogen synthase gene in hypertensive and normotensive subjects.

Schalin-Jäntti C, Nikula-Ijäs P, Huang X, Lehto M, Knudsen P, Syvänne M, Lehtovirta MT, Tikkanen T, Tikkanen I, Groop LC.

Hypertension. 1996 Jan;27(1):67-71.

15.

Increased renal expression of cytokines and growth factors induced by DOCA-NaCl treatment in Heymann nephritis.

Tikkanen I, Uhlenius N, Tikkanen T, Miettinen A, Törnroth T, Fyhrquist F, Holthöfer H.

Nephrol Dial Transplant. 1995 Dec;10(12):2192-8.

PMID:
8808210
16.

[Angiotensin II antagonists].

Tikkanen I, Tikkanen T.

Duodecim. 1995;111(18):1733-5. Finnish. No abstract available.

PMID:
9340266
17.

[Diagnosis and therapy of renovascular hypertension].

Tikkanen T, Laasonen L, Tikkanen I.

Duodecim. 1995;111(15):1453-60. Review. Finnish. No abstract available.

PMID:
9244701
18.

[Pseudohypertension--a rare or common problem in the treatment of hypertension].

Tikkanen T, Lindgren L, Tikkanen I, Fyhrquist F.

Duodecim. 1995;111(9):858-62. Finnish. No abstract available.

PMID:
8681849
19.

A study of the effects of lisinopril when used in addition to atenolol.

Soininen K, Gerlin-Piira L, Suihkonen J, Kyllönen T, Parviainen R, Kyllönen E, Hämäläinen K, Lonka R, Tikkanen T, Selonen R, et al.

J Hum Hypertens. 1992 Aug;6(4):321-4.

PMID:
1331443
20.

Prolonged neutral endopeptidase inhibition in heart failure.

Helin K, Tikkanen I, Tikkanen T, Saijonmaa O, Sybertz EJ, Vemulapalli S, Sariola H, Fyhrquist F.

Eur J Pharmacol. 1991 May 30;198(1):23-30.

PMID:
1655477

Supplemental Content

Loading ...
Support Center